← Back
$GLUE All transactions

Monte Rosa Therapeutics, Inc.

A

$ Value

Shares

4,300

Price

Filed

Apr 7

Insider

Name

Bowen Matthew

Title

Principal Accounting Officer

CIK

0002115025

Roles

Officer

Transaction Details

Transaction Date

2026-04-06

Code

A

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

25,904

Footnotes

Represents restricted stock units ("RSUs") granted under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock upon vesting and settlement. 25% of the RSUs shall vest on April 6, 2027, with the remainder vesting in 3 equal annual installments thereafter, subject to the Reporting Person's continued service on each such vesting date. | 25% of this option shall vest and become exercisable on April 6, 2027, with the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the Reporting Person's continued service on each such vesting date.

Filing Info

Accession No.

0001193125-26-145545

Form Type

4

Issuer CIK

0001826457

Bowen Matthew's History

Date Ticker Type Value
2026-04-06 GLUE A
2026-04-06 GLUE A $0

Other Insiders at GLUE (90d)

Insider Bought Sold Last
Warmuth Markus
President & CEO
$141K 2026-04-14
Janku Filip
Chief Medical Officer
$179K 2026-02-23
Nickson Philip
Chief Business & Legal Officer
$103K 2026-04-09
Bowen Matthew
Principal Accounting Officer
2026-04-06